314 Hits
SVM vlogs
Dec 21, 2021, 3:10 PM
New research on semaglutide and empagliflozin appear on this year’s list of most-read diabetes articles.
In 2021, the glucagon-like peptide-1 receptor agonist (GLP-1 RA) semaglutide was the focus of 3 of the 5 most popular diabetes news stories reported on AJMC.com, the website of The American Journal of Managed Care® (AJMC®). Rounding out the list was a story on clinical factors that can predict patients’ response to glucose-lowering therapies and reported results of the EMPEROR-Preserved trial assessing empagliflozin in heart failure with preserved ejection fraction (HFpEF).
Read More
297 Hits
SVM vlogs
Dec 21, 2021, 3:01 PM
As businesses across the Region continue to make their mark, we are continuously given more and more great news to...
Read More
326 Hits
SVM vlogs
Dec 21, 2021, 6:09 AM
Ancient DNA from a mammoth molar and a new source of gravitational waves made the list
Read More
